Stockreport

CVRx's stock up as heart failure device to be trialled in expanded patient group [Yahoo! Finance]

CVRx, Inc.  (CVRX) 
PDF In the BENEFIT-HF clinical trial (NCT07232030), Barostim will be trialled in patients with heart failure who remain symptomatic after receiving optimised guideline-dire [Read more]